{
  "id": 3603948,
  "title": "GLP-1 Drugs Could Help Narrow Lifespan Gap in Serious Mental Illness",
  "url": "https://urgent.news/2026/08/26/glp-1-drugs-could-help-narrow-lifespan-gap-in-serious-mental-illness",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-26T21:42:17.000Z",
  "source": {
    "name": "MedPage Today",
    "slug": "medpage-today",
    "url": "https://www.medpagetoday.com/psychiatry/generalpsychiatry/122778"
  },
  "original_language": "en",
  "account": "A recent study suggests that GLP-1 receptor agonist medications may help reduce the lifespan gap among individuals with serious mental illness (SMI), according to a target trial emulation. Compared to SGLT2 inhibitor initiators, GLP-1 drug initiators were found to have a 24% lower 4-year mortality risk. The study, led by Roger McIntyre from the University of Toronto, also revealed that the association persisted across sensitivity analyses. The findings indicate that GLP-1 drugs may offer cardiometabolic benefits beyond their isolated outcomes. Life expectancy for individuals with SMI is typically 10 to 25 years shorter than the general population, primarily due to cardiovascular disease. The researchers suggest that the anti-inflammatory and anti-atherogenic effects of GLP-1 drugs, as well as their potential impact on motivation, behavior, cognitive organization, and the mitigation of risk factors like alcohol use disorder, may contribute to the observed risk reduction.",
  "summary": "(MedPage Today) -- Starting a GLP-1 receptor agonist was associated with significantly lower risks of death and cardiovascular events in adults with serious mental illness (SMI), a target trial emulation showed. Among 195,184 propensity score...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}